This finding extends our previous report on the catabolic properties of ADAMTS-5 on vascular proteoglycans and its ability to alter proteoglycan-mediated lipoprotein retention in a mouse model of atherosclerosis.23 This evidence concerns the gene ADAMTS5 and atherosclerosis.